Aptevo Therapeutics Inc.
Aptevo Therapeutics Inc. is a risky bet given it's low Altman Z-score. Companies with a low Altman Z-score have a higher chance of going bankrupt within the next 2 years. Aptevo Therapeutics Inc. could be a weak company given it's low Piotroski F-score. The momentum for this stock is not very good. Aptevo Therapeutics Inc. is a mediocre stock to choose.
Log in to see more information.
Aptevo Therapeutics, Inc. is a biotechnology company, which engages in the discovery, development, c...
News
Aptevo Therapeutics (NASDAQ:APVO) Receives New Coverage from Analysts at StockNews.com
Ticker Report StockNews.com started coverage on shares of Aptevo Therapeutics (NASDAQ:APVO - Free Report) in a research note released on Wednesday. The firm issued a sell rating on the biotechnology company's...\n more…
Aptevo Therapeutics (NASDAQ:APVO) Coverage Initiated by Analysts at StockNews.com
Ticker Report StockNews.com assumed coverage on shares of Aptevo Therapeutics (NASDAQ:APVO - Free Report) in a research report report published on Tuesday. The brokerage issued a sell rating on the biotechnology...\n more…
Aptevo Therapeutics files to sell 13.51M shares of common stock
SeekingAlpha.com: All News Aptevo Therapeutics (APVO) filed a financial Filing. Stay updated on their financial activities and performance.\n more…
